Clinical aspects of intravenous immunoglobulin use in solid organ transplant recipients.
about
Issues in solid-organ transplantation in children: translational research from bench to bedside.Preoperative selective desensitization of live donor liver transplant recipients considering the degree of T lymphocyte cross-match titer, model for end-stage liver disease score, and graft liver volumeImmunosuppressive Medications.Antibody-mediated rejection: an evolving entity in heart transplantation.Review article: BK virus in systemic lupus erythematosusABO-incompatible living donor kidney transplantation without post-transplant therapeutic plasma exchange.Current progress in ABO-incompatible kidney transplantationRational clinical trial design for antibody mediated renal allograft injury.Implications for Interleukin-33 in solid organ transplantationAntibody-mediated Rejection in Lung Transplantation.Fever, haematuria, and acute graft dysfunction in renal transplant recipients secondary to adenovirus infection: two case reports.Impact of Desensitization on Antiviral Immunity in HLA-Sensitized Kidney Transplant Recipients.Clearance of BK Virus Nephropathy by Combination Antiviral Therapy With Intravenous ImmunoglobulinBK viruria and viremia in children with systemic lupus erythematosus.Regulation of immunity and inflammation by intravenous immunoglobulin: relevance to solid organ transplantation.Incompatible kidney transplantation: a brief overview of the past, present and future.Disruptions in the supply of medications used in transplantation: implications and management strategies for the transplant clinician.Immunosuppression and allograft rejection following lung transplantation: evidence to date.The expanding role of therapeutic antibodies.Acute and chronic antibody-mediated rejection in pediatric kidney transplantation.Methodological aspects of anti-human leukocyte antigen antibody analysis in solid organ transplantation.Achieving incompatible transplantation through desensitization: current perspectives and future directions.Antibody replacement therapy in primary antibody deficiencies and iatrogenic hypogammaglobulinemia.A national survey of screening and management of hypogammaglobulinemia in Canadian transplantation centers.The importance of non-HLA antibodies in transplantation.Renal safety of high-dose, sucrose-free intravenous immunoglobulin in kidney transplant recipients: an observational study.Case Report: Renal Transplantation in Patients with Pre-existing Hypogammaglobulinemia.Successful Transplantation in ABO- and HLA-Incompatible Living Kidney Transplant Patients: A Report on 12 Cases.Resolution of Mild Ganciclovir-Resistant Cytomegalovirus Disease with Reduced-Dose Cidofovir and CMV-Hyperimmune Globulin.Low incidence of acute rejection in hepatitis B virus positive liver transplant recipients and the impact of hepatitis B immunoglobulin.Herpes simplex virus 2 hepatitis in a lung transplant recipient: a diagnostic challenge.Anesthetic management in ABO incompatible kidney transplant.Does increasing immunoglobulin levels impact survival in solid organ transplant recipients with hypogammaglobulinemia?The Cost of Transplant Immunosuppressant Therapy: Is This Sustainable?What is the impact of hypogammaglobulinemia on the rate of infections and survival in solid organ transplantation? A meta-analysis.Human parvovirus B19 in solid organ transplantation.Pharmaceutical costs of desensitization therapy in patients awaiting lung transplantation in France.Anti-HLA sensitization after kidney allograft nephrectomy: changes one year post-surgery and beneficial effect of intravenous immunoglobulin.Severe allograft rejection in an intestinal transplant patient following oral immunoglobulin treatment for chronic norovirus infection: a case report.
P2860
Q27023312-7B35A602-FA5A-4E0B-9682-D9E4E02E6C5CQ33627543-CFF4A916-7971-4163-ACCB-ECF63A24D5FFQ34484801-85AAE2A0-DD0D-4A7C-8ED9-6FD501F41EA3Q35876250-A72ED4DC-26C5-4612-8F4C-FA13AAABDF65Q35986282-0B5C9340-5130-48C7-BCD3-485E146A7BF9Q36031039-017DDEF9-C2E2-4B0B-999F-9AA1CAFB59E9Q36171175-95F8EF62-4870-40A9-BB6B-36EBD2F7E3EAQ36173541-4280776E-5C26-45DB-9246-83A84E85A562Q36807908-211894A6-5B37-428D-A168-921451AFA015Q37441785-EC7D45BF-FFA9-4420-9196-3FF67C7D26E2Q37556192-46EE3AB9-5FA4-4FDB-91F0-05BBA8617406Q37652611-EA44004A-96EC-447F-872D-684392D12DC9Q37738744-7EEEE5C4-F8F2-46C6-8190-8444B2605727Q37747582-6E6CE97A-F2E8-4F3A-BFB1-3082E741188FQ37877263-CF5338EF-5713-4EAE-BFD9-128F039CBCE3Q38036246-1A48AEE1-1BA4-40DE-8F30-9E50037913EDQ38057787-2BC1D78A-3817-4DAE-9278-889F0F9A80ABQ38154197-6B1E6EE6-A148-4E93-9CA6-575134BC2099Q38182645-6E93DB02-189F-4F9A-BFF3-AE872F232226Q38215262-0D4EA933-7627-4E2B-AFFB-72DD8E86F71AQ38262909-47BBAAEA-4E67-4193-8882-2B2DA7787588Q38445336-5626E60E-C9B5-4882-AAA9-D1489723BC25Q38548417-CD22A942-E389-4413-9F24-1BE040A51E78Q38830258-C5994E09-9BE1-4B0D-A2FA-D0B0150D14BAQ38877375-8147B078-FA84-4887-AF88-D98E2FCED08AQ39485911-928E76E4-0532-41CE-A90C-72238226E271Q40198981-5FDBAF61-030E-488C-9573-D15C663C645CQ40503602-FA739F60-1F07-4763-BB59-CF16FCA48B5CQ40745646-764140EA-4D3F-4727-8426-03F3E09458BDQ40774233-F61A6DF7-9C1D-4543-AE44-05E8745707F3Q41000404-FBA23F15-5D18-45A8-AF3A-8CC6B56B6849Q41055116-B463333A-2614-4B98-91D1-E89D6797B033Q41746594-28C47AAC-16BE-4E79-B19E-564253701608Q41774477-827230EE-111A-4750-85C7-D2B85D9CA138Q42252234-54C86373-D155-4376-95DC-574D12093372Q42272309-3122E6EF-382D-418C-BD2A-CB31D241559FQ47866596-1A325771-26CB-44E1-A78E-4F6D768D49AEQ53108441-1EB1D883-A6CD-4614-8AE0-EC5B8FB32FC3Q55513212-F3528F43-8D82-4639-8704-1DCB22FEE074
P2860
Clinical aspects of intravenous immunoglobulin use in solid organ transplant recipients.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 January 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Clinical aspects of intravenous immunoglobulin use in solid organ transplant recipients.
@en
Clinical aspects of intravenous immunoglobulin use in solid organ transplant recipients.
@nl
type
label
Clinical aspects of intravenous immunoglobulin use in solid organ transplant recipients.
@en
Clinical aspects of intravenous immunoglobulin use in solid organ transplant recipients.
@nl
prefLabel
Clinical aspects of intravenous immunoglobulin use in solid organ transplant recipients.
@en
Clinical aspects of intravenous immunoglobulin use in solid organ transplant recipients.
@nl
P2093
P2860
P1476
Clinical aspects of intravenous immunoglobulin use in solid organ transplant recipients.
@en
P2093
P2860
P304
P356
10.1111/J.1600-6143.2010.03400.X
P407
P577
2011-01-10T00:00:00Z